6 months ago
2
Indian Immunologicals Limited (IIL), 1 of India’s starring vaccine manufacturers, has issued a clarification connected Saturday (December 27, 2025) regarding caller reports surrounding its quality anti-rabies vaccine, Abhayrab.
In it’s connection it said that the company powerfully refuted the over-cautionary and misplaced Australian wellness advisory adding that the counterfeiting incidental that has been mentioned involving it’s rabies vaccine Abhayrab — Batch No.KA24014 (manufacturing date: March 2024; expiry date: February 2027) — was identified by aboriginal January 2025. The counterfeit batch is nary longer disposable connected the shelves, it said.
Earlier this week the Australian Technical Advisory Group connected Immunisation issued an alert astir counterfeit batches of the vaccine Abhayrab circulating successful India since November 1, 2023.
It said that Australian travellers who person been administered with Anti-Rabies vaccine - Abhayrab successful India aft November 1, 2023, should see the vaccination invalid and initiate a caller people of vaccination.
Rabies is simply a viral zoonotic illness that affects the cardinal tense system. It’s astir ever fatal erstwhile symptoms develop, but it is preventable with contiguous aesculapian attraction aft exposure.
In it’s connection the institution further said that the vaccine has been manufactured by IIL since 2000, with much than 210 cardinal doses supplied crossed India and 40 countries, and continues to clasp a 40% marketplace stock successful India.
“In January 2025, IIL identified a packaging anomaly successful 1 circumstantial batch (Batch # KA 24014). The institution instantly notified Indian regulators and instrumentality enforcement agencies, lodged a ceremonial complaint, and worked intimately with authorities to guarantee swift action,” it said adding that this is an isolated incident, and the counterfeit batch is nary longer disposable connected the shelves.
Reassuring healthcare professionals and the public, IIL emphasized that each batch of vaccine manufactured successful India is tested and released by the Central Drugs Laboratory (Government of India) earlier being made disposable for merchantability oregon administration.
“Supplies made done authorities institutions and authorized distributors stay harmless and of modular quality,” said Sunil Tiwari, Vice President & Head of Quality Management astatine IIL.
The Company has besides written to the Australian Technical Advisory Group connected Immunisation stating that Abhayrab, a purified compartment culture-based Rabies vaccine is manufactured successful accordance with applicable regulatory requirements including WHO Good Manufacturing Practices (GMP) and applicable pharmacopeial standards.
It added that the merchandise is intended for usage successful some pre-exposure and post-exposure prophylaxis against rabies and has been supplied done authorities procurement channels arsenic good arsenic the backstage healthcare sector.
“Every batch of vaccine manufactured successful India is tested and released by National Control Laboratory (Central Drugs Laboratory), which is simply a WHO-Geneva pre-qualified laboratory nether National Regulatory Authority,” it added.
Meanwhile, earlier this period the Centers for Disease Control and Prevention besides issued wellness warnings for India and Haiti aft travelers from those countries were diagnosed with rabies.
In its advisory travellers were advised to debar interaction with dogs, cats, and chaotic mammals successful some countries.
